866-997-4948(US-Canada Toll Free)

United States Peptide Antibiotics Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 108 Pages

In this report, the United States Peptide Antibiotics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Peptide Antibiotics in these regions, from 2012 to 2022 (forecast).

United States Peptide Antibiotics market competition by top manufacturers/players, with Peptide Antibiotics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Peptide Antibiotics for each application, including
Pharma & Healthcare
Food Industry
Commodities
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Peptide Antibiotics Market Report 2017
1 Peptide Antibiotics Overview
1.1 Product Overview and Scope of Peptide Antibiotics
1.2 Classification of Peptide Antibiotics by Product Category
1.2.1 United States Peptide Antibiotics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Peptide Antibiotics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Ribosomal Synthesized Peptide Antibiotics
1.2.4 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 United States Peptide Antibiotics Market by Application/End Users
1.3.1 United States Peptide Antibiotics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 United States Peptide Antibiotics Market by Region
1.4.1 United States Peptide Antibiotics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Peptide Antibiotics Status and Prospect (2012-2022)
1.4.3 Southwest Peptide Antibiotics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Peptide Antibiotics Status and Prospect (2012-2022)
1.4.5 New England Peptide Antibiotics Status and Prospect (2012-2022)
1.4.6 The South Peptide Antibiotics Status and Prospect (2012-2022)
1.4.7 The Midwest Peptide Antibiotics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Peptide Antibiotics (2012-2022)
1.5.1 United States Peptide Antibiotics Sales and Growth Rate (2012-2022)
1.5.2 United States Peptide Antibiotics Revenue and Growth Rate (2012-2022)

2 United States Peptide Antibiotics Market Competition by Players/Suppliers
2.1 United States Peptide Antibiotics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Peptide Antibiotics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Peptide Antibiotics Average Price by Players/Suppliers (2012-2017)
2.4 United States Peptide Antibiotics Market Competitive Situation and Trends
2.4.1 United States Peptide Antibiotics Market Concentration Rate
2.4.2 United States Peptide Antibiotics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Peptide Antibiotics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Peptide Antibiotics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Peptide Antibiotics Sales and Market Share by Region (2012-2017)
3.2 United States Peptide Antibiotics Revenue and Market Share by Region (2012-2017)
3.3 United States Peptide Antibiotics Price by Region (2012-2017)

4 United States Peptide Antibiotics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Peptide Antibiotics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Peptide Antibiotics Revenue and Market Share by Type (2012-2017)
4.3 United States Peptide Antibiotics Price by Type (2012-2017)
4.4 United States Peptide Antibiotics Sales Growth Rate by Type (2012-2017)

5 United States Peptide Antibiotics Sales (Volume) by Application (2012-2017)
5.1 United States Peptide Antibiotics Sales and Market Share by Application (2012-2017)
5.2 United States Peptide Antibiotics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Peptide Antibiotics Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Peptide Antibiotics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Peptide Antibiotics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
6.3.2 Peptide Antibiotics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Eli Lilly
6.4.2 Peptide Antibiotics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Theravance
6.5.2 Peptide Antibiotics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Theravance Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Vicuron Pharmaceuticals
6.6.2 Peptide Antibiotics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Savara Pharmaceuticals
6.7.2 Peptide Antibiotics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AMP Therapeutics
6.8.2 Peptide Antibiotics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Hospira
6.9.2 Peptide Antibiotics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hospira Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Kasten
6.10.2 Peptide Antibiotics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Kasten Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Madam Therapeutics
6.12 Phosphagenics
6.13 Pacgen Life Science Corporation

7 Peptide Antibiotics Manufacturing Cost Analysis
7.1 Peptide Antibiotics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Peptide Antibiotics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Peptide Antibiotics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peptide Antibiotics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Peptide Antibiotics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Peptide Antibiotics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Peptide Antibiotics Sales Volume Forecast by Type (2017-2022)
11.3 United States Peptide Antibiotics Sales Volume Forecast by Application (2017-2022)
11.4 United States Peptide Antibiotics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Peptide Antibiotics
Figure United States Peptide Antibiotics Market Size (MT) by Type (2012-2022)
Figure United States Peptide Antibiotics Sales Volume Market Share by Type (Product Category) in 2016
Figure Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Figure United States Peptide Antibiotics Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Peptide Antibiotics by Application in 2016
Figure Pharma & Healthcare Examples
Table Key Downstream Customer in Pharma & Healthcare
Figure Food Industry Examples
Table Key Downstream Customer in Food Industry
Figure Commodities Examples
Table Key Downstream Customer in Commodities
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Peptide Antibiotics Market Size (Million USD) by Region (2012-2022)
Figure The West Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptide Antibiotics Sales (MT) and Growth Rate (2012-2022)
Figure United States Peptide Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptide Antibiotics Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Peptide Antibiotics Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Peptide Antibiotics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptide Antibiotics Sales Share by Players/Suppliers
Figure 2017 United States Peptide Antibiotics Sales Share by Players/Suppliers
Figure United States Peptide Antibiotics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Peptide Antibiotics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Peptide Antibiotics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptide Antibiotics Revenue Share by Players/Suppliers
Figure 2017 United States Peptide Antibiotics Revenue Share by Players/Suppliers
Table United States Market Peptide Antibiotics Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Peptide Antibiotics Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Peptide Antibiotics Market Share of Top 3 Players/Suppliers
Figure United States Peptide Antibiotics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Peptide Antibiotics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Peptide Antibiotics Product Category
Table United States Peptide Antibiotics Sales (MT) by Region (2012-2017)
Table United States Peptide Antibiotics Sales Share by Region (2012-2017)
Figure United States Peptide Antibiotics Sales Share by Region (2012-2017)
Figure United States Peptide Antibiotics Sales Market Share by Region in 2016
Table United States Peptide Antibiotics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Peptide Antibiotics Revenue Share by Region (2012-2017)
Figure United States Peptide Antibiotics Revenue Market Share by Region (2012-2017)
Figure United States Peptide Antibiotics Revenue Market Share by Region in 2016
Table United States Peptide Antibiotics Price (USD/Kg) by Region (2012-2017)
Table United States Peptide Antibiotics Sales (MT) by Type (2012-2017)
Table United States Peptide Antibiotics Sales Share by Type (2012-2017)
Figure United States Peptide Antibiotics Sales Share by Type (2012-2017)
Figure United States Peptide Antibiotics Sales Market Share by Type in 2016
Table United States Peptide Antibiotics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Peptide Antibiotics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptide Antibiotics by Type (2012-2017)
Figure Revenue Market Share of Peptide Antibiotics by Type in 2016
Table United States Peptide Antibiotics Price (USD/Kg) by Types (2012-2017)
Figure United States Peptide Antibiotics Sales Growth Rate by Type (2012-2017)
Table United States Peptide Antibiotics Sales (MT) by Application (2012-2017)
Table United States Peptide Antibiotics Sales Market Share by Application (2012-2017)
Figure United States Peptide Antibiotics Sales Market Share by Application (2012-2017)
Figure United States Peptide Antibiotics Sales Market Share by Application in 2016
Table United States Peptide Antibiotics Sales Growth Rate by Application (2012-2017)
Figure United States Peptide Antibiotics Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Pfizer Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Pfizer Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Novartis Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Novartis Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Eli Lilly Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Eli Lilly Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Theravance Basic Information List
Table Theravance Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Theravance Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Theravance Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Theravance Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Vicuron Pharmaceuticals Basic Information List
Table Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Vicuron Pharmaceuticals Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Vicuron Pharmaceuticals Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Vicuron Pharmaceuticals Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Savara Pharmaceuticals Basic Information List
Table Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Savara Pharmaceuticals Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Savara Pharmaceuticals Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Savara Pharmaceuticals Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table AMP Therapeutics Basic Information List
Table AMP Therapeutics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AMP Therapeutics Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure AMP Therapeutics Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure AMP Therapeutics Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Hospira Basic Information List
Table Hospira Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Hospira Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Hospira Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Hospira Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Kasten Basic Information List
Table Kasten Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Kasten Peptide Antibiotics Sales Growth Rate (2012-2017)
Figure Kasten Peptide Antibiotics Sales Market Share in United States (2012-2017)
Figure Kasten Peptide Antibiotics Revenue Market Share in United States (2012-2017)
Table Madam Therapeutics Basic Information List
Table Phosphagenics Basic Information List
Table Pacgen Life Science Corporation Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Antibiotics
Figure Manufacturing Process Analysis of Peptide Antibiotics
Figure Peptide Antibiotics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Antibiotics Major Players/Suppliers in 2016
Table Major Buyers of Peptide Antibiotics
Table Distributors/Traders List
Figure United States Peptide Antibiotics Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Peptide Antibiotics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Peptide Antibiotics Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Peptide Antibiotics Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Peptide Antibiotics Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Peptide Antibiotics Sales Volume (MT) Forecast by Type in 2022
Table United States Peptide Antibiotics Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Peptide Antibiotics Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Peptide Antibiotics Sales Volume (MT) Forecast by Application in 2022
Table United States Peptide Antibiotics Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Peptide Antibiotics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptide Antibiotics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptide Antibiotics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *